€2B
Annual revenue
The company needed to align its industrial footprint with ambitious growth targets through 2030. EFESO worked with the in-house team to develop and implement a comprehensive strategy encompassing factory rationalization, plant optimization and supply chain improvements. This transformation redefined operations across the company’s entire manufacturing network.
Industry: Life Sciences
Service: Cost and Value Engineering
Service: Operations Strategy and Transformation
Service: Supply Chain
The company is a €2 billion multinational pharmaceutical and dermo-cosmetics company. As one of the largest private pharmaceutical groups and among the largest dermo-cosmetics laboratories worldwide, the company operates a complex global manufacturing network.
The company combines pharmaceutical expertise with dermo-cosmetic innovation across multiple production facilities.
€2B
Annual revenue
#2
Global dermo-cosmetics position
The company faced the complex task of aligning its entire industrial footprint with long-term business objectives spanning a decade. Key operational constraints included:
The partnership delivered a comprehensive industrial roadmap that fundamentally transformed the company’s operational capabilities.
Working alongside its teams for nearly a decade, we have enabled sustainable improvements to be made across its entire manufacturing and supply chain network.
€100M
Savings realized
-15%
Annual CapEx reduction
€40-50M
Yearly investment optimization